Genetically Modifying Patients’ Skin Cells to Treat Rare Diseases
RARECast - Podcast autorstwa RARECast - Czwartki
Kategorie:
Matthew Gantz, president and CEO of Castle Creek Biosciences, discusses the company’s experimental therapy for RDEB, how it works, and how the company is building out its pipeline through dealmaking.
